Aung-Htut, May T. http://orcid.org/0000-0002-6379-2303
Comerford, Iain
Johnsen, Russell
Foyle, Kerrie
Fletcher, Sue
Wilton, Steve D.
Funding for this research was provided by:
Multiple Sclerosis Research Australia
Perron Institute for Neurological and Translational Science
Article History
Received: 13 May 2019
Accepted: 19 August 2019
First Online: 10 September 2019
Competing Interests
: M.T.A.-H., S.F. and S.D.W. are named inventors of a patent describing the down-regulation of ITGA4: Multiple Sclerosis Treatment (20180104273), filed by Murdoch University, inventors: Stephen Donald Wilton, Sue Fletcher, May Aung-Htut, application status: pending. The <i>in vitro</i> validation experiments in this manuscript covered patent application. This has not been licensed to any commercial interests. S.F. and S.D.W. are consultants for Sarepta Therapeutics, and M.T.A.-H.’s salary is partly supported by Sarepta Therapeutics. This association has not influenced this work in any fashion.